Small-Cap Stock Watch: Key Catalysts This Week (February 2–6)

From corporate updates to investor events, we’ve tracked the full scope of small-cap catalysts slated for the week ahead.

Companies with Material Events This Week

● RIME — Will attend and exhibit at Link 2026: The Retail Supply Chain Conference, hosted by the Retail Industry Leaders Association. The event takes place from February 1–4, 2026, at the Gaylord Palms Hotel in Orlando, Florida, and brings together leaders from over 100 national retailers, logistics providers, technology innovators, and supply chain executives.

● BMR — Will showcase a validation framework for AI-enhanced and compressed video quality at Mile High Video 2026, held February 2–5, 2026, in Denver, Colorado. The company will demonstrate how broadcasters and streaming platforms can maintain viewer-perceived quality while managing infrastructure costs and scaling Ultra HD and AI-based workflows.

● STKE — Will participate in the Canaccord Digital Asset Event on February 4, 2026, in London, England, contributing to discussions on innovation and strategy in digital asset technologies.

● SMTK — Has until February 3, 2026, to finalize a definitive agreement under its amended non-binding LOI with Jericho Energy Ventures. The amendment extended the exclusivity period and required SMTK to purchase $500,000 of Jericho shares by December 31, 2025. The proposed transaction would focus on building synergies in energy innovation and technology commercialization.

● VSEE — Will host a webinar titled “On-demand ICU: Future of Sustainable Rural Healthcare” on February 4, 2026, from 11:00 AM to 12:00 PM PT. The event will feature DocBox CEO Bobby Shah and be moderated by VSee Health Co-CEO Dr. Milton Chen, discussing mobile ICU infrastructure to support high-acuity care in rural hospitals.

● XTIA — Will host an Investor Town Hall on February 5, 2026, at 4:30 PM ET, where the leadership team will share strategic priorities for 2026 following the acquisition of Drone Nerds. The company will outline its repositioning strategy and expectations for long-term growth and revenue visibility.

● PMI — Will present in the DeviceTalks Tuesdays webcast series on February 3, 2026, at 12:00 PM ET. COO Matt Schuster will present “The Emperor: A Fully Implantable, Mechanically Driven Next-Generation SynCardia Total Artificial Heart,” including bench and in vivo data, hemodynamic performance, and insights on system development.

● NERV — Will host a virtual KOL event on February 3, 2026, at 10:30 AM ET featuring experts Dr. Gregory Strauss and Dr. Brian Kirkpatrick, along with company leadership. The discussion will cover the patient burden of negative symptoms in schizophrenia and how the upcoming Phase 3 trial of roluperidone is structured to meet regulatory expectations.

● SINT — Will present at the Noble Capital Markets Emerging Growth Virtual Equity Conference taking place February 4–5, 2026. The company will update investors on recent restructuring, its medtech strategy, and financial visibility following a focused operational transition.

● SNAL — Will participate in the Noble Capital Markets Emerging Growth Virtual Conference on February 4, 2026, through virtual one-on-one investor meetings.

● KBSX — Will present at the Noble Virtual Conference on February 4, 2026, at 1:30 PM ET. CFO Sebastian Tadla and VP of Investor Relations Kathee Lin will conduct a fireside-style Q&A session and host investor 1x1s.

● ICU — Will present at the Noble Capital Markets Emerging Growth Virtual Conference on February 5, 2026, at 11:30 AM ET. CEO Eric Schlorff will provide a live company update.

● XAIR — Will present at the same Noble conference on February 5, 2026, at 2:00 PM ET. Chairman and CEO Steve Lisi will lead the session, which includes a virtual presentation and one-on-one investor meetings.

● COCH — Will participate in the Small Cap Growth Virtual Investor Conference on February 5, 2026, where management will engage investors with updates on company strategy.

● ADGM — Will also present at the Small Cap Growth Virtual Investor Conference hosted by VirtualInvestorConferences.com on February 5, 2026, offering a live webcast session.

● XCUR — Will present a poster at the 2026 Tandem Meetings (ASTCT & CIBMTR), taking place February 4–7, 2026, in Salt Lake City, Utah. The presentation will highlight findings in transplantation and cellular therapy aligned with the company’s pipeline.

● ARTV — Will present new data at the 2026 Tandem Meetings, February 4–7, 2026, in Salt Lake City, Utah. Topics include the cost-effectiveness of AlloNK in community rheumatology practices and its sustained efficacy in treating Non-Hodgkin Lymphoma.

● AMIX — Will present final clinical data at the Society of Interventional Oncology (SIO) 2026 Annual Meeting in Savannah, GA, February 4–8, 2026. The ePoster, “Pain Mitigation in Pancreatic Adenocarcinoma,” will be presented February 6, 2026, from 5:30 to 6:30 PM ET.

● RNXT — Will also present at SIO 2026, scheduled from February 4–8, 2026, in Savannah, Georgia. The company’s accepted abstract relates to innovations in interventional oncology.

● ZBAO — Will present at the Skyline Signature Series on February 3, 2026, at 12:00 PM ET. Executives will provide corporate updates and host a live Q&A session with investors.

● GRWG — Will participate in the Oppenheimer 11th Annual Emerging Growth Conference, taking place virtually February 3–4, 2026, with one-on-one investor meetings throughout the event.

● PAYS — Will also participate in the Oppenheimer conference. CFO Jeff Baker will host one-on-one investor meetings on February 3, 2026.

● VLN — Will conduct one-on-one meetings virtually during the Oppenheimer Emerging Growth Conference on February 4, 2026.

● VVPR — Will present at the Noble Capital Markets Emerging Growth Virtual Conference on February 5, 2026, at 3:30 PM ET. Executive Chairman Kevin Chin and CIO Alex Cuppage will lead the fireside-style presentation and participate in investor meetings.

● ZENA — Will participate in Noble’s Emerging Growth Virtual Equity Conference on February 5, 2026. The company will deliver a virtual presentation and conduct one-on-one meetings.

● ANGX — Will present during the Oppenheimer Emerging Growth Conference, which will be held virtually February 3–4, 2026.

● IPST — Will present at the RedChip Fintech & DATS Virtual Investor Conference on February 4, 2026, at 3:00 PM ET. CEO Justin Stiefel will outline IP Strategy’s validator-based model and AI-native data infrastructure used for scalable monetization of digital IP.

● FFAI — Will host its FF EAI Robotics Product Final Launch event on February 4, 2026, from 3:00 to 4:30 PM PT at NADA Show 2026 in Las Vegas, followed by the invite-only FF/FX Partner Summit on February 5, 2026. The events will include product demos, pricing announcements, and recruitment of sales partners for the company’s advanced embodied AI robots.

● TYGO — Will exhibit the Tigo GO Battery and its new VPP-compatible capabilities at RE+ Northeast in Boston, MA, from February 4–5, 2026. The product is now fully integrated with the Tigo EI Residential Solution and DERMS platforms such as EnergyHub and Uplight.

● LAES — Will present secure semiconductor technologies and post-quantum cryptography at Tech&Fest 2026, taking place February 4–5, 2026, in Grenoble, France. Its French subsidiary SEALSQ France will exhibit alongside other European deeptech companies.

● RedChip — Will host its Fintech & DATS (Digital Asset Treasury Strategy) Virtual Investor Conference on February 4, 2026, from 9:30 AM to 4:00 PM ET. The event features public companies focused on digital asset infrastructure, payments, and fintech, offering direct access to executives via live sessions and virtual meetings. Participating companies include OWLS, BGL, MMA, and ENLV.

--

Disclaimer: All content provided by BigTimePennys Report is for informational purposes only. The information provided should not be considered as a substitute for professional advice, analysis, or guidance. Any investment decisions made based on the information provided are solely at the user's own risk. BigTimePennys Report are not liable for any losses or damages incurred as a result of using this information. BigTimePenny is not operated by a licensed broker, a dealer, or a registered investment adviser. The Securities Litigation Reform Act of 1995 provides safe harbor protection for forward-looking statements made by companies or individuals. It should be noted that any forward-looking statements made by BigTimePennys Report, its authors, are not guarantees of future performance or results. These statements are subject to risks, uncertainties, and assumptions that may cause actual results to differ materially from those expressed or implied in the forward-looking statements. The content provided by BigTimePennys Report does not constitute an endorsement, recommendation, or solicitation to buy, sell, or hold any securities or investment products. BigTimePennys Report, its authors, do not endorse or recommend any specific investment strategies, securities, or companies. It is crucial to conduct thorough research and seek advice from a qualified professional before making any investment decisions. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. The user assumes full responsibility for the use of the information provided by BigTimePennys Report. BigTimePennys Report, its authors, disclaim any liability for any direct, indirect, or consequential damages arising from the use or reliance on the information provided. Users should exercise their own judgment and discretion when interpreting and utilizing the information provided. Please note that the content provided by BigTimePennys Report is based on available information and sources believed to be reliable. However, market conditions and regulations may change over time, and there may be inaccuracies or errors in the information provided. It is recommended to verify the information with current and reliable sources before making any investment decisions. Investing in micro-cap companies is highly speculative and carries an extremely high degree of risk. BigTimePenny is not a fiduciary by virtue of any person's use of or access to this content. We were NOT compensated for this article.